nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—EGFR—sarcoma	0.474	1	CbGaD
Lidocaine—CYP2B6—Thiotepa—sarcoma	0.0664	0.181	CbGbCtD
Lidocaine—SLC22A5—Dactinomycin—sarcoma	0.0645	0.176	CbGbCtD
Lidocaine—CYP1A2—Dacarbazine—sarcoma	0.0216	0.0588	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0206	0.0562	CbGbCtD
Lidocaine—CYP3A7—Vincristine—sarcoma	0.0206	0.0562	CbGbCtD
Lidocaine—CYP3A4—Thiotepa—sarcoma	0.0204	0.0556	CbGbCtD
Lidocaine—ABCB1—Dactinomycin—sarcoma	0.0164	0.0446	CbGbCtD
Lidocaine—CYP3A5—Vincristine—sarcoma	0.0155	0.0422	CbGbCtD
Lidocaine—ABCB1—Mitoxantrone—sarcoma	0.0146	0.0399	CbGbCtD
Lidocaine—CYP3A5—Etoposide—sarcoma	0.0142	0.0387	CbGbCtD
Lidocaine—CYP2C8—Etoposide—sarcoma	0.0136	0.0372	CbGbCtD
Lidocaine—CYP2B6—Doxorubicin—sarcoma	0.0123	0.0335	CbGbCtD
Lidocaine—CYP1A2—Etoposide—sarcoma	0.0106	0.0288	CbGbCtD
Lidocaine—ABCB1—Vincristine—sarcoma	0.0101	0.0275	CbGbCtD
Lidocaine—ABCB1—Etoposide—sarcoma	0.00923	0.0252	CbGbCtD
Lidocaine—CYP3A4—Mitoxantrone—sarcoma	0.00877	0.0239	CbGbCtD
Lidocaine—ABCB1—Doxorubicin—sarcoma	0.0063	0.0172	CbGbCtD
Lidocaine—CYP3A4—Vincristine—sarcoma	0.00604	0.0165	CbGbCtD
Lidocaine—CYP2D6—Doxorubicin—sarcoma	0.00593	0.0162	CbGbCtD
Lidocaine—CYP3A4—Etoposide—sarcoma	0.00553	0.0151	CbGbCtD
Lidocaine—CYP3A4—Doxorubicin—sarcoma	0.00377	0.0103	CbGbCtD
Lidocaine—EGFR—mammary gland—sarcoma	0.00083	0.0804	CbGeAlD
Lidocaine—EGFR—uterus—sarcoma	0.000382	0.037	CbGeAlD
Lidocaine—SCN2A—hematopoietic system—sarcoma	0.000329	0.0318	CbGeAlD
Lidocaine—SCN10A—hematopoietic system—sarcoma	0.000317	0.0307	CbGeAlD
Lidocaine—CYP2A6—seminal vesicle—sarcoma	0.000304	0.0294	CbGeAlD
Lidocaine—Sweating increased—Etoposide—sarcoma	0.000278	0.00331	CcSEcCtD
Lidocaine—EGFR—testis—sarcoma	0.000277	0.0268	CbGeAlD
Lidocaine—Erythema—Thiotepa—sarcoma	0.000277	0.0033	CcSEcCtD
Lidocaine—Haemoglobin—Mitoxantrone—sarcoma	0.000276	0.00329	CcSEcCtD
Lidocaine—SCN9A—tendon—sarcoma	0.000276	0.0267	CbGeAlD
Lidocaine—Rhinitis—Mitoxantrone—sarcoma	0.000276	0.00328	CcSEcCtD
Lidocaine—Erythema—Dactinomycin—sarcoma	0.000275	0.00327	CcSEcCtD
Lidocaine—SLC22A5—mammary gland—sarcoma	0.000275	0.0266	CbGeAlD
Lidocaine—Haemorrhage—Mitoxantrone—sarcoma	0.000275	0.00327	CcSEcCtD
Lidocaine—Tension—Thiotepa—sarcoma	0.000272	0.00323	CcSEcCtD
Lidocaine—Dysarthria—Epirubicin—sarcoma	0.00027	0.00321	CcSEcCtD
Lidocaine—Nervousness—Thiotepa—sarcoma	0.000269	0.0032	CcSEcCtD
Lidocaine—Back pain—Thiotepa—sarcoma	0.000268	0.00319	CcSEcCtD
Lidocaine—CYP2C8—mammary gland—sarcoma	0.000266	0.0258	CbGeAlD
Lidocaine—Atrioventricular block—Epirubicin—sarcoma	0.000263	0.00313	CcSEcCtD
Lidocaine—EGFR—liver—sarcoma	0.000262	0.0254	CbGeAlD
Lidocaine—Cardiac disorder—Vincristine—sarcoma	0.000262	0.00312	CcSEcCtD
Lidocaine—Vision blurred—Thiotepa—sarcoma	0.000261	0.00311	CcSEcCtD
Lidocaine—Angiopathy—Vincristine—sarcoma	0.000256	0.00305	CcSEcCtD
Lidocaine—Ventricular tachycardia—Epirubicin—sarcoma	0.000255	0.00304	CcSEcCtD
Lidocaine—Agitation—Thiotepa—sarcoma	0.000255	0.00303	CcSEcCtD
Lidocaine—Dermatitis contact—Epirubicin—sarcoma	0.000252	0.003	CcSEcCtD
Lidocaine—Dysarthria—Doxorubicin—sarcoma	0.00025	0.00297	CcSEcCtD
Lidocaine—Neuropathy peripheral—Etoposide—sarcoma	0.00025	0.00297	CcSEcCtD
Lidocaine—Stomatitis—Etoposide—sarcoma	0.000248	0.00295	CcSEcCtD
Lidocaine—Chills—Mitoxantrone—sarcoma	0.000247	0.00293	CcSEcCtD
Lidocaine—SCN4A—tendon—sarcoma	0.000246	0.0238	CbGeAlD
Lidocaine—Skin exfoliation—Epirubicin—sarcoma	0.000244	0.0029	CcSEcCtD
Lidocaine—Atrioventricular block—Doxorubicin—sarcoma	0.000244	0.0029	CcSEcCtD
Lidocaine—Convulsion—Thiotepa—sarcoma	0.00024	0.00286	CcSEcCtD
Lidocaine—Neuropathy—Epirubicin—sarcoma	0.00024	0.00285	CcSEcCtD
Lidocaine—Erythema—Mitoxantrone—sarcoma	0.000239	0.00285	CcSEcCtD
Lidocaine—Hypertension—Thiotepa—sarcoma	0.000239	0.00285	CcSEcCtD
Lidocaine—Back pain—Vincristine—sarcoma	0.000238	0.00283	CcSEcCtD
Lidocaine—CYP2C9—mammary gland—sarcoma	0.000236	0.0229	CbGeAlD
Lidocaine—Ventricular tachycardia—Doxorubicin—sarcoma	0.000236	0.00281	CcSEcCtD
Lidocaine—Anxiety—Thiotepa—sarcoma	0.000235	0.0028	CcSEcCtD
Lidocaine—Dysgeusia—Mitoxantrone—sarcoma	0.000234	0.00279	CcSEcCtD
Lidocaine—Dermatitis contact—Doxorubicin—sarcoma	0.000233	0.00278	CcSEcCtD
Lidocaine—Coma—Epirubicin—sarcoma	0.000233	0.00277	CcSEcCtD
Lidocaine—Back pain—Mitoxantrone—sarcoma	0.000232	0.00275	CcSEcCtD
Lidocaine—SCN9A—testis—sarcoma	0.000228	0.0221	CbGeAlD
Lidocaine—Confusional state—Thiotepa—sarcoma	0.000228	0.00271	CcSEcCtD
Lidocaine—Hypoaesthesia—Etoposide—sarcoma	0.000228	0.00271	CcSEcCtD
Lidocaine—CYP2C18—liver—sarcoma	0.000226	0.0219	CbGeAlD
Lidocaine—Agitation—Vincristine—sarcoma	0.000226	0.00269	CcSEcCtD
Lidocaine—Vision blurred—Mitoxantrone—sarcoma	0.000226	0.00268	CcSEcCtD
Lidocaine—Skin exfoliation—Doxorubicin—sarcoma	0.000225	0.00268	CcSEcCtD
Lidocaine—Oedema—Dactinomycin—sarcoma	0.000224	0.00267	CcSEcCtD
Lidocaine—SCN10A—lymphoid tissue—sarcoma	0.000223	0.0216	CbGeAlD
Lidocaine—Nervous system disorder—Thiotepa—sarcoma	0.000222	0.00264	CcSEcCtD
Lidocaine—Neuropathy—Doxorubicin—sarcoma	0.000222	0.00264	CcSEcCtD
Lidocaine—SCN5A—cardiac atrium—sarcoma	0.000219	0.0212	CbGeAlD
Lidocaine—Coma—Doxorubicin—sarcoma	0.000216	0.00257	CcSEcCtD
Lidocaine—CYP3A7—liver—sarcoma	0.000215	0.0209	CbGeAlD
Lidocaine—Eye disorder—Etoposide—sarcoma	0.000214	0.00254	CcSEcCtD
Lidocaine—Convulsion—Vincristine—sarcoma	0.000213	0.00253	CcSEcCtD
Lidocaine—Flushing—Etoposide—sarcoma	0.000212	0.00252	CcSEcCtD
Lidocaine—Cardiac disorder—Etoposide—sarcoma	0.000212	0.00252	CcSEcCtD
Lidocaine—Hypertension—Vincristine—sarcoma	0.000212	0.00252	CcSEcCtD
Lidocaine—Angiopathy—Etoposide—sarcoma	0.000207	0.00247	CcSEcCtD
Lidocaine—Convulsion—Mitoxantrone—sarcoma	0.000207	0.00247	CcSEcCtD
Lidocaine—Hypertension—Mitoxantrone—sarcoma	0.000207	0.00246	CcSEcCtD
Lidocaine—Immune system disorder—Etoposide—sarcoma	0.000207	0.00246	CcSEcCtD
Lidocaine—Chills—Etoposide—sarcoma	0.000205	0.00244	CcSEcCtD
Lidocaine—Chest pain—Mitoxantrone—sarcoma	0.000204	0.00242	CcSEcCtD
Lidocaine—SCN4A—testis—sarcoma	0.000204	0.0197	CbGeAlD
Lidocaine—Paraesthesia—Thiotepa—sarcoma	0.000203	0.00242	CcSEcCtD
Lidocaine—Anxiety—Mitoxantrone—sarcoma	0.000203	0.00241	CcSEcCtD
Lidocaine—Somnolence—Thiotepa—sarcoma	0.000201	0.00239	CcSEcCtD
Lidocaine—EGFR—lymph node—sarcoma	0.000201	0.0195	CbGeAlD
Lidocaine—Anaphylactic shock—Vincristine—sarcoma	0.000201	0.00239	CcSEcCtD
Lidocaine—Oedema—Vincristine—sarcoma	0.000201	0.00239	CcSEcCtD
Lidocaine—Confusional state—Mitoxantrone—sarcoma	0.000197	0.00234	CcSEcCtD
Lidocaine—Nervous system disorder—Vincristine—sarcoma	0.000197	0.00234	CcSEcCtD
Lidocaine—Oedema—Mitoxantrone—sarcoma	0.000195	0.00232	CcSEcCtD
Lidocaine—Anaphylactic shock—Mitoxantrone—sarcoma	0.000195	0.00232	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Thiotepa—sarcoma	0.000195	0.00232	CcSEcCtD
Lidocaine—SLC22A5—myometrium—sarcoma	0.000195	0.0189	CbGeAlD
Lidocaine—Dysgeusia—Etoposide—sarcoma	0.000195	0.00232	CcSEcCtD
Lidocaine—Hyperhidrosis—Vincristine—sarcoma	0.000194	0.00231	CcSEcCtD
Lidocaine—Dermatitis bullous—Epirubicin—sarcoma	0.000194	0.00231	CcSEcCtD
Lidocaine—Pain—Thiotepa—sarcoma	0.000193	0.0023	CcSEcCtD
Lidocaine—Back pain—Etoposide—sarcoma	0.000193	0.00229	CcSEcCtD
Lidocaine—Shock—Mitoxantrone—sarcoma	0.000192	0.00229	CcSEcCtD
Lidocaine—Pain—Dactinomycin—sarcoma	0.000192	0.00228	CcSEcCtD
Lidocaine—Anaphylactoid reaction—Epirubicin—sarcoma	0.000191	0.00228	CcSEcCtD
Lidocaine—SCN3A—tendon—sarcoma	0.000191	0.0185	CbGeAlD
Lidocaine—Hyperhidrosis—Mitoxantrone—sarcoma	0.000189	0.00225	CcSEcCtD
Lidocaine—Hypotension—Vincristine—sarcoma	0.000187	0.00223	CcSEcCtD
Lidocaine—Feeling abnormal—Thiotepa—sarcoma	0.000186	0.00222	CcSEcCtD
Lidocaine—SCN3A—bone marrow—sarcoma	0.000185	0.0179	CbGeAlD
Lidocaine—Osteoarthritis—Epirubicin—sarcoma	0.000185	0.0022	CcSEcCtD
Lidocaine—Diplopia—Epirubicin—sarcoma	0.000185	0.0022	CcSEcCtD
Lidocaine—Feeling abnormal—Dactinomycin—sarcoma	0.000185	0.0022	CcSEcCtD
Lidocaine—CYP3A7-CYP3A51P—liver—sarcoma	0.000183	0.0177	CbGeAlD
Lidocaine—Hypotension—Mitoxantrone—sarcoma	0.000183	0.00217	CcSEcCtD
Lidocaine—Paraesthesia—Vincristine—sarcoma	0.00018	0.00214	CcSEcCtD
Lidocaine—Urticaria—Thiotepa—sarcoma	0.00018	0.00214	CcSEcCtD
Lidocaine—Dermatitis bullous—Doxorubicin—sarcoma	0.000179	0.00213	CcSEcCtD
Lidocaine—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000177	0.00211	CcSEcCtD
Lidocaine—SLC22A5—seminal vesicle—sarcoma	0.000176	0.0171	CbGeAlD
Lidocaine—Cardiac arrest—Epirubicin—sarcoma	0.000176	0.0021	CcSEcCtD
Lidocaine—Paraesthesia—Mitoxantrone—sarcoma	0.000175	0.00209	CcSEcCtD
Lidocaine—Loss of consciousness—Etoposide—sarcoma	0.000175	0.00208	CcSEcCtD
Lidocaine—Dyspnoea—Mitoxantrone—sarcoma	0.000174	0.00207	CcSEcCtD
Lidocaine—Somnolence—Mitoxantrone—sarcoma	0.000174	0.00206	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Vincristine—sarcoma	0.000173	0.00206	CcSEcCtD
Lidocaine—Convulsion—Etoposide—sarcoma	0.000172	0.00205	CcSEcCtD
Lidocaine—Hypertension—Etoposide—sarcoma	0.000172	0.00204	CcSEcCtD
Lidocaine—Pain—Vincristine—sarcoma	0.000172	0.00204	CcSEcCtD
Lidocaine—Osteoarthritis—Doxorubicin—sarcoma	0.000171	0.00204	CcSEcCtD
Lidocaine—Diplopia—Doxorubicin—sarcoma	0.000171	0.00204	CcSEcCtD
Lidocaine—Chest pain—Etoposide—sarcoma	0.000169	0.00202	CcSEcCtD
Lidocaine—Pain—Mitoxantrone—sarcoma	0.000167	0.00199	CcSEcCtD
Lidocaine—Hypersensitivity—Thiotepa—sarcoma	0.000167	0.00198	CcSEcCtD
Lidocaine—SCN9A—lymph node—sarcoma	0.000165	0.016	CbGeAlD
Lidocaine—Hypersensitivity—Dactinomycin—sarcoma	0.000165	0.00197	CcSEcCtD
Lidocaine—Confusional state—Etoposide—sarcoma	0.000164	0.00195	CcSEcCtD
Lidocaine—Cardiac arrest—Doxorubicin—sarcoma	0.000163	0.00194	CcSEcCtD
Lidocaine—Anaphylactic shock—Etoposide—sarcoma	0.000162	0.00193	CcSEcCtD
Lidocaine—Asthenia—Thiotepa—sarcoma	0.000162	0.00193	CcSEcCtD
Lidocaine—CYP2C8—hematopoietic system—sarcoma	0.000162	0.0157	CbGeAlD
Lidocaine—Asthenia—Dactinomycin—sarcoma	0.000161	0.00192	CcSEcCtD
Lidocaine—Feeling abnormal—Mitoxantrone—sarcoma	0.000161	0.00191	CcSEcCtD
Lidocaine—Dysphagia—Epirubicin—sarcoma	0.00016	0.0019	CcSEcCtD
Lidocaine—Asthma—Epirubicin—sarcoma	0.00016	0.0019	CcSEcCtD
Lidocaine—SCN3A—testis—sarcoma	0.000158	0.0153	CbGeAlD
Lidocaine—Hyperhidrosis—Etoposide—sarcoma	0.000157	0.00187	CcSEcCtD
Lidocaine—Urticaria—Mitoxantrone—sarcoma	0.000155	0.00185	CcSEcCtD
Lidocaine—Hypotension—Etoposide—sarcoma	0.000152	0.00181	CcSEcCtD
Lidocaine—CYP1A2—hematopoietic system—sarcoma	0.000152	0.0147	CbGeAlD
Lidocaine—CYP2A6—liver—sarcoma	0.00015	0.0145	CbGeAlD
Lidocaine—Dizziness—Thiotepa—sarcoma	0.00015	0.00178	CcSEcCtD
Lidocaine—Asthma—Doxorubicin—sarcoma	0.000148	0.00176	CcSEcCtD
Lidocaine—Dysphagia—Doxorubicin—sarcoma	0.000148	0.00176	CcSEcCtD
Lidocaine—Hypersensitivity—Vincristine—sarcoma	0.000148	0.00176	CcSEcCtD
Lidocaine—CYP3A5—hematopoietic system—sarcoma	0.000146	0.0142	CbGeAlD
Lidocaine—Paraesthesia—Etoposide—sarcoma	0.000146	0.00173	CcSEcCtD
Lidocaine—SLC22A5—skin of body—sarcoma	0.000146	0.0141	CbGeAlD
Lidocaine—CYP2B6—hematopoietic system—sarcoma	0.000145	0.0141	CbGeAlD
Lidocaine—Dyspnoea—Etoposide—sarcoma	0.000145	0.00172	CcSEcCtD
Lidocaine—Somnolence—Etoposide—sarcoma	0.000144	0.00172	CcSEcCtD
Lidocaine—CYP2C9—hematopoietic system—sarcoma	0.000144	0.0139	CbGeAlD
Lidocaine—Hypersensitivity—Mitoxantrone—sarcoma	0.000144	0.00171	CcSEcCtD
Lidocaine—Asthenia—Vincristine—sarcoma	0.000144	0.00171	CcSEcCtD
Lidocaine—Vomiting—Thiotepa—sarcoma	0.000144	0.00171	CcSEcCtD
Lidocaine—Drowsiness—Epirubicin—sarcoma	0.000143	0.0017	CcSEcCtD
Lidocaine—Vomiting—Dactinomycin—sarcoma	0.000143	0.0017	CcSEcCtD
Lidocaine—Rash—Thiotepa—sarcoma	0.000143	0.0017	CcSEcCtD
Lidocaine—Dermatitis—Thiotepa—sarcoma	0.000142	0.00169	CcSEcCtD
Lidocaine—Headache—Thiotepa—sarcoma	0.000142	0.00168	CcSEcCtD
Lidocaine—Rash—Dactinomycin—sarcoma	0.000142	0.00168	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Etoposide—sarcoma	0.00014	0.00167	CcSEcCtD
Lidocaine—Asthenia—Mitoxantrone—sarcoma	0.00014	0.00167	CcSEcCtD
Lidocaine—Neuropathy peripheral—Epirubicin—sarcoma	0.00014	0.00166	CcSEcCtD
Lidocaine—Stomatitis—Epirubicin—sarcoma	0.000139	0.00166	CcSEcCtD
Lidocaine—Pain—Etoposide—sarcoma	0.000139	0.00165	CcSEcCtD
Lidocaine—Nausea—Thiotepa—sarcoma	0.000134	0.0016	CcSEcCtD
Lidocaine—Feeling abnormal—Etoposide—sarcoma	0.000134	0.00159	CcSEcCtD
Lidocaine—Nausea—Dactinomycin—sarcoma	0.000133	0.00159	CcSEcCtD
Lidocaine—Dizziness—Vincristine—sarcoma	0.000133	0.00158	CcSEcCtD
Lidocaine—Drowsiness—Doxorubicin—sarcoma	0.000132	0.00157	CcSEcCtD
Lidocaine—Bradycardia—Epirubicin—sarcoma	0.000131	0.00155	CcSEcCtD
Lidocaine—Neuropathy peripheral—Doxorubicin—sarcoma	0.00013	0.00154	CcSEcCtD
Lidocaine—Urticaria—Etoposide—sarcoma	0.000129	0.00153	CcSEcCtD
Lidocaine—Haemoglobin—Epirubicin—sarcoma	0.000129	0.00153	CcSEcCtD
Lidocaine—Stomatitis—Doxorubicin—sarcoma	0.000129	0.00153	CcSEcCtD
Lidocaine—Rhinitis—Epirubicin—sarcoma	0.000129	0.00153	CcSEcCtD
Lidocaine—Haemorrhage—Epirubicin—sarcoma	0.000128	0.00152	CcSEcCtD
Lidocaine—Hypoaesthesia—Epirubicin—sarcoma	0.000128	0.00152	CcSEcCtD
Lidocaine—Vomiting—Vincristine—sarcoma	0.000128	0.00152	CcSEcCtD
Lidocaine—SLC22A5—cardiac atrium—sarcoma	0.000127	0.0123	CbGeAlD
Lidocaine—CYP2B6—skin of body—sarcoma	0.000126	0.0122	CbGeAlD
Lidocaine—Rash—Vincristine—sarcoma	0.000126	0.0015	CcSEcCtD
Lidocaine—Dermatitis—Vincristine—sarcoma	0.000126	0.0015	CcSEcCtD
Lidocaine—SCN10A—lymph node—sarcoma	0.000126	0.0122	CbGeAlD
Lidocaine—Headache—Vincristine—sarcoma	0.000126	0.00149	CcSEcCtD
Lidocaine—Vomiting—Mitoxantrone—sarcoma	0.000124	0.00148	CcSEcCtD
Lidocaine—Visual impairment—Epirubicin—sarcoma	0.000124	0.00147	CcSEcCtD
Lidocaine—Rash—Mitoxantrone—sarcoma	0.000123	0.00146	CcSEcCtD
Lidocaine—Dermatitis—Mitoxantrone—sarcoma	0.000123	0.00146	CcSEcCtD
Lidocaine—Headache—Mitoxantrone—sarcoma	0.000122	0.00146	CcSEcCtD
Lidocaine—Bradycardia—Doxorubicin—sarcoma	0.000121	0.00144	CcSEcCtD
Lidocaine—Eye disorder—Epirubicin—sarcoma	0.00012	0.00142	CcSEcCtD
Lidocaine—Hypersensitivity—Etoposide—sarcoma	0.00012	0.00142	CcSEcCtD
Lidocaine—Tinnitus—Epirubicin—sarcoma	0.00012	0.00142	CcSEcCtD
Lidocaine—Haemoglobin—Doxorubicin—sarcoma	0.000119	0.00142	CcSEcCtD
Lidocaine—Nausea—Vincristine—sarcoma	0.000119	0.00142	CcSEcCtD
Lidocaine—Cardiac disorder—Epirubicin—sarcoma	0.000119	0.00141	CcSEcCtD
Lidocaine—Flushing—Epirubicin—sarcoma	0.000119	0.00141	CcSEcCtD
Lidocaine—Rhinitis—Doxorubicin—sarcoma	0.000119	0.00141	CcSEcCtD
Lidocaine—Haemorrhage—Doxorubicin—sarcoma	0.000119	0.00141	CcSEcCtD
Lidocaine—Hypoaesthesia—Doxorubicin—sarcoma	0.000118	0.0014	CcSEcCtD
Lidocaine—Asthenia—Etoposide—sarcoma	0.000117	0.00139	CcSEcCtD
Lidocaine—Angiopathy—Epirubicin—sarcoma	0.000116	0.00138	CcSEcCtD
Lidocaine—Nausea—Mitoxantrone—sarcoma	0.000116	0.00138	CcSEcCtD
Lidocaine—Immune system disorder—Epirubicin—sarcoma	0.000116	0.00138	CcSEcCtD
Lidocaine—Chills—Epirubicin—sarcoma	0.000115	0.00137	CcSEcCtD
Lidocaine—SCN3A—lymph node—sarcoma	0.000115	0.0111	CbGeAlD
Lidocaine—Visual impairment—Doxorubicin—sarcoma	0.000114	0.00136	CcSEcCtD
Lidocaine—Erythema—Epirubicin—sarcoma	0.000112	0.00133	CcSEcCtD
Lidocaine—SLC22A5—tendon—sarcoma	0.000111	0.0107	CbGeAlD
Lidocaine—Eye disorder—Doxorubicin—sarcoma	0.000111	0.00132	CcSEcCtD
Lidocaine—Tinnitus—Doxorubicin—sarcoma	0.000111	0.00132	CcSEcCtD
Lidocaine—Flushing—Doxorubicin—sarcoma	0.00011	0.00131	CcSEcCtD
Lidocaine—Cardiac disorder—Doxorubicin—sarcoma	0.00011	0.00131	CcSEcCtD
Lidocaine—CYP3A4—hematopoietic system—sarcoma	0.00011	0.0106	CbGeAlD
Lidocaine—Tension—Epirubicin—sarcoma	0.00011	0.0013	CcSEcCtD
Lidocaine—Dysgeusia—Epirubicin—sarcoma	0.000109	0.0013	CcSEcCtD
Lidocaine—Nervousness—Epirubicin—sarcoma	0.000108	0.00129	CcSEcCtD
Lidocaine—CYP2D6—hematopoietic system—sarcoma	0.000108	0.0105	CbGeAlD
Lidocaine—Back pain—Epirubicin—sarcoma	0.000108	0.00128	CcSEcCtD
Lidocaine—Angiopathy—Doxorubicin—sarcoma	0.000108	0.00128	CcSEcCtD
Lidocaine—Dizziness—Etoposide—sarcoma	0.000107	0.00128	CcSEcCtD
Lidocaine—Immune system disorder—Doxorubicin—sarcoma	0.000107	0.00127	CcSEcCtD
Lidocaine—Chills—Doxorubicin—sarcoma	0.000106	0.00127	CcSEcCtD
Lidocaine—Vision blurred—Epirubicin—sarcoma	0.000105	0.00125	CcSEcCtD
Lidocaine—Vomiting—Etoposide—sarcoma	0.000103	0.00123	CcSEcCtD
Lidocaine—Erythema—Doxorubicin—sarcoma	0.000103	0.00123	CcSEcCtD
Lidocaine—Agitation—Epirubicin—sarcoma	0.000103	0.00122	CcSEcCtD
Lidocaine—Rash—Etoposide—sarcoma	0.000102	0.00122	CcSEcCtD
Lidocaine—CYP2B6—lymphoid tissue—sarcoma	0.000102	0.00991	CbGeAlD
Lidocaine—Dermatitis—Etoposide—sarcoma	0.000102	0.00122	CcSEcCtD
Lidocaine—Headache—Etoposide—sarcoma	0.000102	0.00121	CcSEcCtD
Lidocaine—Tension—Doxorubicin—sarcoma	0.000101	0.0012	CcSEcCtD
Lidocaine—Dysgeusia—Doxorubicin—sarcoma	0.000101	0.0012	CcSEcCtD
Lidocaine—Nervousness—Doxorubicin—sarcoma	0.0001	0.00119	CcSEcCtD
Lidocaine—Back pain—Doxorubicin—sarcoma	9.99e-05	0.00119	CcSEcCtD
Lidocaine—Loss of consciousness—Epirubicin—sarcoma	9.81e-05	0.00117	CcSEcCtD
Lidocaine—Vision blurred—Doxorubicin—sarcoma	9.73e-05	0.00116	CcSEcCtD
Lidocaine—Convulsion—Epirubicin—sarcoma	9.67e-05	0.00115	CcSEcCtD
Lidocaine—Nausea—Etoposide—sarcoma	9.65e-05	0.00115	CcSEcCtD
Lidocaine—Hypertension—Epirubicin—sarcoma	9.63e-05	0.00115	CcSEcCtD
Lidocaine—Chest pain—Epirubicin—sarcoma	9.5e-05	0.00113	CcSEcCtD
Lidocaine—Agitation—Doxorubicin—sarcoma	9.49e-05	0.00113	CcSEcCtD
Lidocaine—Anxiety—Epirubicin—sarcoma	9.47e-05	0.00113	CcSEcCtD
Lidocaine—Confusional state—Epirubicin—sarcoma	9.18e-05	0.00109	CcSEcCtD
Lidocaine—SLC22A5—testis—sarcoma	9.18e-05	0.00889	CbGeAlD
Lidocaine—Anaphylactic shock—Epirubicin—sarcoma	9.11e-05	0.00108	CcSEcCtD
Lidocaine—Oedema—Epirubicin—sarcoma	9.11e-05	0.00108	CcSEcCtD
Lidocaine—Loss of consciousness—Doxorubicin—sarcoma	9.08e-05	0.00108	CcSEcCtD
Lidocaine—ABCB1—myometrium—sarcoma	9.06e-05	0.00877	CbGeAlD
Lidocaine—Shock—Epirubicin—sarcoma	8.96e-05	0.00107	CcSEcCtD
Lidocaine—Convulsion—Doxorubicin—sarcoma	8.95e-05	0.00106	CcSEcCtD
Lidocaine—Nervous system disorder—Epirubicin—sarcoma	8.93e-05	0.00106	CcSEcCtD
Lidocaine—Hypertension—Doxorubicin—sarcoma	8.91e-05	0.00106	CcSEcCtD
Lidocaine—CYP2C8—testis—sarcoma	8.89e-05	0.0086	CbGeAlD
Lidocaine—Hyperhidrosis—Epirubicin—sarcoma	8.8e-05	0.00105	CcSEcCtD
Lidocaine—Chest pain—Doxorubicin—sarcoma	8.79e-05	0.00105	CcSEcCtD
Lidocaine—Anxiety—Doxorubicin—sarcoma	8.76e-05	0.00104	CcSEcCtD
Lidocaine—ABCB1—embryo—sarcoma	8.71e-05	0.00843	CbGeAlD
Lidocaine—SLC22A5—liver—sarcoma	8.68e-05	0.0084	CbGeAlD
Lidocaine—Hypotension—Epirubicin—sarcoma	8.51e-05	0.00101	CcSEcCtD
Lidocaine—Confusional state—Doxorubicin—sarcoma	8.5e-05	0.00101	CcSEcCtD
Lidocaine—Oedema—Doxorubicin—sarcoma	8.43e-05	0.001	CcSEcCtD
Lidocaine—Anaphylactic shock—Doxorubicin—sarcoma	8.43e-05	0.001	CcSEcCtD
Lidocaine—CYP2C8—liver—sarcoma	8.4e-05	0.00813	CbGeAlD
Lidocaine—Shock—Doxorubicin—sarcoma	8.29e-05	0.000986	CcSEcCtD
Lidocaine—Nervous system disorder—Doxorubicin—sarcoma	8.26e-05	0.000983	CcSEcCtD
Lidocaine—ABCB1—seminal vesicle—sarcoma	8.18e-05	0.00792	CbGeAlD
Lidocaine—Paraesthesia—Epirubicin—sarcoma	8.18e-05	0.000972	CcSEcCtD
Lidocaine—Hyperhidrosis—Doxorubicin—sarcoma	8.15e-05	0.000969	CcSEcCtD
Lidocaine—Dyspnoea—Epirubicin—sarcoma	8.12e-05	0.000966	CcSEcCtD
Lidocaine—Somnolence—Epirubicin—sarcoma	8.1e-05	0.000963	CcSEcCtD
Lidocaine—CYP2B6—testis—sarcoma	7.97e-05	0.00772	CbGeAlD
Lidocaine—Hypotension—Doxorubicin—sarcoma	7.87e-05	0.000936	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Epirubicin—sarcoma	7.86e-05	0.000935	CcSEcCtD
Lidocaine—CYP1A2—liver—sarcoma	7.86e-05	0.00761	CbGeAlD
Lidocaine—Pain—Epirubicin—sarcoma	7.79e-05	0.000926	CcSEcCtD
Lidocaine—ABCB1—hematopoietic system—sarcoma	7.78e-05	0.00753	CbGeAlD
Lidocaine—CYP3A5—liver—sarcoma	7.58e-05	0.00734	CbGeAlD
Lidocaine—Paraesthesia—Doxorubicin—sarcoma	7.57e-05	0.0009	CcSEcCtD
Lidocaine—CYP2B6—liver—sarcoma	7.54e-05	0.0073	CbGeAlD
Lidocaine—Dyspnoea—Doxorubicin—sarcoma	7.51e-05	0.000893	CcSEcCtD
Lidocaine—Feeling abnormal—Epirubicin—sarcoma	7.5e-05	0.000892	CcSEcCtD
Lidocaine—Somnolence—Doxorubicin—sarcoma	7.49e-05	0.000891	CcSEcCtD
Lidocaine—CYP2C9—liver—sarcoma	7.46e-05	0.00722	CbGeAlD
Lidocaine—Gastrointestinal disorder—Doxorubicin—sarcoma	7.28e-05	0.000865	CcSEcCtD
Lidocaine—Urticaria—Epirubicin—sarcoma	7.24e-05	0.00086	CcSEcCtD
Lidocaine—Pain—Doxorubicin—sarcoma	7.21e-05	0.000857	CcSEcCtD
Lidocaine—Feeling abnormal—Doxorubicin—sarcoma	6.94e-05	0.000826	CcSEcCtD
Lidocaine—Hypersensitivity—Epirubicin—sarcoma	6.71e-05	0.000798	CcSEcCtD
Lidocaine—Urticaria—Doxorubicin—sarcoma	6.69e-05	0.000796	CcSEcCtD
Lidocaine—SLC22A5—lymph node—sarcoma	6.65e-05	0.00644	CbGeAlD
Lidocaine—Asthenia—Epirubicin—sarcoma	6.53e-05	0.000777	CcSEcCtD
Lidocaine—Hypersensitivity—Doxorubicin—sarcoma	6.21e-05	0.000738	CcSEcCtD
Lidocaine—Asthenia—Doxorubicin—sarcoma	6.05e-05	0.000719	CcSEcCtD
Lidocaine—Dizziness—Epirubicin—sarcoma	6.02e-05	0.000716	CcSEcCtD
Lidocaine—CYP2D6—testis—sarcoma	5.92e-05	0.00573	CbGeAlD
Lidocaine—ABCB1—uterus—sarcoma	5.87e-05	0.00569	CbGeAlD
Lidocaine—Vomiting—Epirubicin—sarcoma	5.79e-05	0.000689	CcSEcCtD
Lidocaine—Rash—Epirubicin—sarcoma	5.74e-05	0.000683	CcSEcCtD
Lidocaine—Dermatitis—Epirubicin—sarcoma	5.74e-05	0.000682	CcSEcCtD
Lidocaine—Headache—Epirubicin—sarcoma	5.71e-05	0.000678	CcSEcCtD
Lidocaine—CYP3A4—liver—sarcoma	5.69e-05	0.00551	CbGeAlD
Lidocaine—CYP2D6—liver—sarcoma	5.6e-05	0.00542	CbGeAlD
Lidocaine—Dizziness—Doxorubicin—sarcoma	5.57e-05	0.000663	CcSEcCtD
Lidocaine—ABCB1—lymphoid tissue—sarcoma	5.47e-05	0.0053	CbGeAlD
Lidocaine—Nausea—Epirubicin—sarcoma	5.41e-05	0.000643	CcSEcCtD
Lidocaine—Vomiting—Doxorubicin—sarcoma	5.36e-05	0.000637	CcSEcCtD
Lidocaine—Rash—Doxorubicin—sarcoma	5.31e-05	0.000632	CcSEcCtD
Lidocaine—Dermatitis—Doxorubicin—sarcoma	5.31e-05	0.000631	CcSEcCtD
Lidocaine—Headache—Doxorubicin—sarcoma	5.28e-05	0.000628	CcSEcCtD
Lidocaine—Nausea—Doxorubicin—sarcoma	5.01e-05	0.000595	CcSEcCtD
Lidocaine—ABCB1—bone marrow—sarcoma	4.98e-05	0.00482	CbGeAlD
Lidocaine—ABCB1—testis—sarcoma	4.26e-05	0.00412	CbGeAlD
Lidocaine—ABCB1—liver—sarcoma	4.03e-05	0.0039	CbGeAlD
Lidocaine—SCN4A—Developmental Biology—VEGFA—sarcoma	3.29e-05	0.000512	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CD34—sarcoma	3.28e-05	0.000511	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—NRAS—sarcoma	3.27e-05	0.00051	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—NRAS—sarcoma	3.27e-05	0.00051	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—NRAS—sarcoma	3.27e-05	0.00051	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—SRC—sarcoma	3.25e-05	0.000507	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—CREB1—sarcoma	3.25e-05	0.000507	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—NRAS—sarcoma	3.25e-05	0.000506	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—NRAS—sarcoma	3.25e-05	0.000506	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—NRAS—sarcoma	3.24e-05	0.000506	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—KRAS—sarcoma	3.23e-05	0.000504	CbGpPWpGaD
Lidocaine—EGFR—Regulation of Actin Cytoskeleton—KRAS—sarcoma	3.23e-05	0.000504	CbGpPWpGaD
Lidocaine—EGFR—Disease—TLE1—sarcoma	3.23e-05	0.000503	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—EGFR—sarcoma	3.22e-05	0.000501	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—NRAS—sarcoma	3.22e-05	0.000501	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—SRC—sarcoma	3.22e-05	0.000501	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—HRAS—sarcoma	3.21e-05	0.0005	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—SRC—sarcoma	3.2e-05	0.000499	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	3.2e-05	0.000499	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—NRAS—sarcoma	3.2e-05	0.000499	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—FOXO1—sarcoma	3.2e-05	0.000499	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—KRAS—sarcoma	3.2e-05	0.000499	CbGpPWpGaD
Lidocaine—ABCB1—Allograft Rejection—VEGFA—sarcoma	3.19e-05	0.000497	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—KRAS—sarcoma	3.18e-05	0.000496	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—MYC—sarcoma	3.18e-05	0.000495	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—VEGFA—sarcoma	3.17e-05	0.000494	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—VEGFA—sarcoma	3.13e-05	0.000488	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—NRAS—sarcoma	3.13e-05	0.000488	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—VEGFA—sarcoma	3.12e-05	0.000486	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	3.12e-05	0.000486	CbGpPWpGaD
Lidocaine—ABCB1—lymph node—sarcoma	3.09e-05	0.00299	CbGeAlD
Lidocaine—SCN5A—Axon guidance—NRAS—sarcoma	3.08e-05	0.00048	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—EGFR—sarcoma	3.08e-05	0.00048	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—KRAS—sarcoma	3.04e-05	0.000474	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—KRAS—sarcoma	3.04e-05	0.000474	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—NRAS—sarcoma	3.03e-05	0.000472	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—MMP2—sarcoma	3.03e-05	0.000472	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—KRAS—sarcoma	3.02e-05	0.000471	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—KRAS—sarcoma	3.02e-05	0.000471	CbGpPWpGaD
Lidocaine—EGFR—Direct p53 effectors—TP53—sarcoma	3.02e-05	0.000471	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—SRC—sarcoma	3.01e-05	0.00047	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—KRAS—sarcoma	3.01e-05	0.000469	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—KRAS—sarcoma	3e-05	0.000467	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—MDM2—sarcoma	2.97e-05	0.000463	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—EGFR—sarcoma	2.96e-05	0.000461	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—EGFR—sarcoma	2.96e-05	0.000461	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—KRAS—sarcoma	2.95e-05	0.00046	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—ENO2—sarcoma	2.94e-05	0.000458	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—KRAS—sarcoma	2.94e-05	0.000458	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—HBA1—sarcoma	2.92e-05	0.000456	CbGpPWpGaD
Lidocaine—EGFR—Disease—NPM1—sarcoma	2.91e-05	0.000454	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—KRAS—sarcoma	2.91e-05	0.000453	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—NRAS—sarcoma	2.9e-05	0.000452	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—HRAS—sarcoma	2.87e-05	0.000448	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	2.87e-05	0.000447	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—EGFR—sarcoma	2.85e-05	0.000444	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—TP53—sarcoma	2.84e-05	0.000443	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	2.84e-05	0.000442	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—FOXO1—sarcoma	2.83e-05	0.00044	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—PDGFRB—sarcoma	2.82e-05	0.00044	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—KRAS—sarcoma	2.82e-05	0.000439	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—KRAS—sarcoma	2.82e-05	0.000439	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—KRAS—sarcoma	2.82e-05	0.000439	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—EGFR—sarcoma	2.81e-05	0.000438	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	2.8e-05	0.000437	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—KRAS—sarcoma	2.79e-05	0.000435	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—KRAS—sarcoma	2.79e-05	0.000435	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—KRAS—sarcoma	2.79e-05	0.000435	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—PDGFRA—sarcoma	2.78e-05	0.000433	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—KRAS—sarcoma	2.77e-05	0.000431	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—KRAS—sarcoma	2.76e-05	0.000429	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—HRAS—sarcoma	2.75e-05	0.000428	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—FOXO1—sarcoma	2.71e-05	0.000423	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—PDGFRB—sarcoma	2.71e-05	0.000422	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—HRAS—sarcoma	2.71e-05	0.000422	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—KRAS—sarcoma	2.69e-05	0.00042	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—PDGFRA—sarcoma	2.67e-05	0.000416	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—KRAS—sarcoma	2.65e-05	0.000413	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	2.65e-05	0.000413	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—KDR—sarcoma	2.65e-05	0.000412	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—TP53—sarcoma	2.61e-05	0.000407	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—KRAS—sarcoma	2.61e-05	0.000406	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—HRAS—sarcoma	2.58e-05	0.000403	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—HRAS—sarcoma	2.58e-05	0.000403	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—HRAS—sarcoma	2.57e-05	0.000401	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—HRAS—sarcoma	2.57e-05	0.000401	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—HRAS—sarcoma	2.56e-05	0.000399	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—HRAS—sarcoma	2.55e-05	0.000397	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—CTNNB1—sarcoma	2.53e-05	0.000394	CbGpPWpGaD
Lidocaine—EGFR—Disease—ENO2—sarcoma	2.52e-05	0.000393	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—sarcoma	2.51e-05	0.000391	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	2.51e-05	0.00039	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PLCG1—sarcoma	2.5e-05	0.000389	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—KRAS—sarcoma	2.5e-05	0.000389	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—HRAS—sarcoma	2.47e-05	0.000385	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—CXCR4—sarcoma	2.44e-05	0.00038	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	2.41e-05	0.000376	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—sarcoma	2.4e-05	0.000373	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—HRAS—sarcoma	2.4e-05	0.000373	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—HRAS—sarcoma	2.4e-05	0.000373	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—HRAS—sarcoma	2.37e-05	0.00037	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—HRAS—sarcoma	2.37e-05	0.00037	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—HRAS—sarcoma	2.37e-05	0.00037	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PTPRC—sarcoma	2.37e-05	0.000369	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	2.36e-05	0.000367	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—HRAS—sarcoma	2.35e-05	0.000367	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—HRAS—sarcoma	2.34e-05	0.000365	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—CREB1—sarcoma	2.32e-05	0.000362	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PLCG1—sarcoma	2.32e-05	0.000361	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—SRC—sarcoma	2.32e-05	0.000361	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—HRAS—sarcoma	2.29e-05	0.000357	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—SRC—sarcoma	2.29e-05	0.000356	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—HRAS—sarcoma	2.26e-05	0.000353	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TLE1—sarcoma	2.26e-05	0.000353	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—HRAS—sarcoma	2.26e-05	0.000351	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—NRAS—sarcoma	2.23e-05	0.000348	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—VEGFA—sarcoma	2.23e-05	0.000347	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—HRAS—sarcoma	2.22e-05	0.000345	CbGpPWpGaD
Lidocaine—EGFR—Immune System—ATF1—sarcoma	2.2e-05	0.000343	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—NRAS—sarcoma	2.2e-05	0.000343	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—MMP2—sarcoma	2.16e-05	0.000337	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—KIT—sarcoma	2.15e-05	0.000336	CbGpPWpGaD
Lidocaine—EGFR—Disease—PLCG1—sarcoma	2.14e-05	0.000334	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—sarcoma	2.12e-05	0.000331	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—SRC—sarcoma	2.1e-05	0.000327	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	2.07e-05	0.000323	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—KIT—sarcoma	2.07e-05	0.000322	CbGpPWpGaD
Lidocaine—EGFR—Disease—CXCR4—sarcoma	2.06e-05	0.000321	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	2.05e-05	0.000319	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CREB1—sarcoma	2.05e-05	0.000319	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—VEGFA—sarcoma	2.04e-05	0.000318	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—NRAS—sarcoma	2.02e-05	0.000315	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—EGFR—sarcoma	2e-05	0.000312	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CREB1—sarcoma	1.97e-05	0.000307	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ENO2—sarcoma	1.96e-05	0.000305	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—HBA1—sarcoma	1.94e-05	0.000303	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—KRAS—sarcoma	1.92e-05	0.000299	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—VEGFC—sarcoma	1.91e-05	0.000297	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—KRAS—sarcoma	1.89e-05	0.000295	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.81e-05	0.000281	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.8e-05	0.000281	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ENO2—sarcoma	1.79e-05	0.000279	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.79e-05	0.000279	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—HBA1—sarcoma	1.78e-05	0.000278	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—KRAS—sarcoma	1.74e-05	0.000271	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—MDM2—sarcoma	1.7e-05	0.000264	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PLCG1—sarcoma	1.66e-05	0.000259	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—CTNNB1—sarcoma	1.66e-05	0.000258	CbGpPWpGaD
Lidocaine—EGFR—Immune System—FOXO1—sarcoma	1.65e-05	0.000256	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PDGFRB—sarcoma	1.64e-05	0.000256	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—HRAS—sarcoma	1.63e-05	0.000254	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—MDM2—sarcoma	1.63e-05	0.000254	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PDGFRA—sarcoma	1.62e-05	0.000252	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.62e-05	0.000252	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—HRAS—sarcoma	1.61e-05	0.000251	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.57e-05	0.000245	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—FLT1—sarcoma	1.53e-05	0.000238	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PLCG1—sarcoma	1.52e-05	0.000237	CbGpPWpGaD
Lidocaine—EGFR—Disease—FOXO1—sarcoma	1.52e-05	0.000237	CbGpPWpGaD
Lidocaine—EGFR—Disease—PDGFRB—sarcoma	1.52e-05	0.000236	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PLCG1—sarcoma	1.5e-05	0.000234	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—SRC—sarcoma	1.5e-05	0.000233	CbGpPWpGaD
Lidocaine—EGFR—Disease—PDGFRA—sarcoma	1.49e-05	0.000233	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—HRAS—sarcoma	1.48e-05	0.00023	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—JUN—sarcoma	1.47e-05	0.00023	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CTNNB1—sarcoma	1.46e-05	0.000228	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—VEGFA—sarcoma	1.46e-05	0.000227	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.45e-05	0.000226	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ENO2—sarcoma	1.45e-05	0.000225	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CXCR4—sarcoma	1.44e-05	0.000225	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—NRAS—sarcoma	1.44e-05	0.000224	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—HBA1—sarcoma	1.44e-05	0.000224	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ATF1—sarcoma	1.42e-05	0.000222	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.42e-05	0.000221	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ENO2—sarcoma	1.41e-05	0.00022	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—HBA1—sarcoma	1.41e-05	0.000219	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.34e-05	0.000209	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—SRC—sarcoma	1.32e-05	0.000206	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—CREB1—sarcoma	1.31e-05	0.000204	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—NRAS—sarcoma	1.27e-05	0.000198	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—SRC—sarcoma	1.27e-05	0.000198	CbGpPWpGaD
Lidocaine—EGFR—Immune System—KIT—sarcoma	1.25e-05	0.000195	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—KRAS—sarcoma	1.24e-05	0.000193	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PLCG1—sarcoma	1.23e-05	0.000191	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ENO2—sarcoma	1.22e-05	0.000191	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—NRAS—sarcoma	1.22e-05	0.00019	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—HBA1—sarcoma	1.22e-05	0.00019	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PLCG1—sarcoma	1.2e-05	0.000187	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CREB1—sarcoma	1.19e-05	0.000186	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.19e-05	0.000185	CbGpPWpGaD
Lidocaine—EGFR—Disease—KIT—sarcoma	1.16e-05	0.00018	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IGF1R—sarcoma	1.12e-05	0.000174	CbGpPWpGaD
Lidocaine—EGFR—Disease—CREB1—sarcoma	1.1e-05	0.000172	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—KRAS—sarcoma	1.09e-05	0.000171	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ENO2—sarcoma	1.07e-05	0.000166	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—FOXO1—sarcoma	1.06e-05	0.000166	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PDGFRB—sarcoma	1.06e-05	0.000166	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—HBA1—sarcoma	1.06e-05	0.000165	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—HRAS—sarcoma	1.05e-05	0.000164	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—KRAS—sarcoma	1.05e-05	0.000164	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PDGFRA—sarcoma	1.05e-05	0.000163	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PLCG1—sarcoma	1.04e-05	0.000162	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ENO2—sarcoma	1.01e-05	0.000157	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—HBA1—sarcoma	9.99e-06	0.000156	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ENO2—sarcoma	9.97e-06	0.000155	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—HBA1—sarcoma	9.91e-06	0.000154	CbGpPWpGaD
Lidocaine—EGFR—Immune System—MDM2—sarcoma	9.88e-06	0.000154	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—IL2—sarcoma	9.66e-06	0.000151	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—HRAS—sarcoma	9.31e-06	0.000145	CbGpPWpGaD
Lidocaine—EGFR—Disease—MDM2—sarcoma	9.12e-06	0.000142	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PLCG1—sarcoma	9.05e-06	0.000141	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—HRAS—sarcoma	8.94e-06	0.000139	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL2—sarcoma	8.83e-06	0.000138	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KDR—sarcoma	8.8e-06	0.000137	CbGpPWpGaD
Lidocaine—EGFR—Immune System—JUN—sarcoma	8.59e-06	0.000134	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PLCG1—sarcoma	8.53e-06	0.000133	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CTNNB1—sarcoma	8.52e-06	0.000133	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ENO2—sarcoma	8.52e-06	0.000133	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—HBA1—sarcoma	8.46e-06	0.000132	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PLCG1—sarcoma	8.46e-06	0.000132	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KIT—sarcoma	8.11e-06	0.000126	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—NRAS—sarcoma	8.11e-06	0.000126	CbGpPWpGaD
Lidocaine—EGFR—Disease—CTNNB1—sarcoma	7.87e-06	0.000123	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CREB1—sarcoma	7.72e-06	0.00012	CbGpPWpGaD
Lidocaine—EGFR—Immune System—SRC—sarcoma	7.7e-06	0.00012	CbGpPWpGaD
Lidocaine—EGFR—Immune System—NRAS—sarcoma	7.41e-06	0.000115	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PLCG1—sarcoma	7.23e-06	0.000113	CbGpPWpGaD
Lidocaine—EGFR—Disease—SRC—sarcoma	7.11e-06	0.000111	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—KRAS—sarcoma	6.98e-06	0.000109	CbGpPWpGaD
Lidocaine—EGFR—Disease—NRAS—sarcoma	6.84e-06	0.000107	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ENO2—sarcoma	6.57e-06	0.000102	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—HBA1—sarcoma	6.53e-06	0.000102	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MDM2—sarcoma	6.39e-06	9.95e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—KRAS—sarcoma	6.38e-06	9.94e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—MYC—sarcoma	6.37e-06	9.93e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HRAS—sarcoma	5.93e-06	9.24e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—KRAS—sarcoma	5.89e-06	9.17e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL2—sarcoma	5.71e-06	8.89e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PLCG1—sarcoma	5.58e-06	8.69e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCND1—sarcoma	5.56e-06	8.67e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—JUN—sarcoma	5.55e-06	8.65e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CTNNB1—sarcoma	5.51e-06	8.58e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HRAS—sarcoma	5.42e-06	8.45e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—HRAS—sarcoma	5e-06	7.8e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SRC—sarcoma	4.98e-06	7.76e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—VEGFA—sarcoma	4.85e-06	7.56e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NRAS—sarcoma	4.79e-06	7.46e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MYC—sarcoma	4.46e-06	6.95e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KRAS—sarcoma	4.12e-06	6.42e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—sarcoma	3.66e-06	5.71e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HRAS—sarcoma	3.5e-06	5.46e-05	CbGpPWpGaD
